✦ LIBER ✦
The efficacy and safety of oral pharmacokinetically enhanced amoxycillin–clavulanate 2000/125 mg, twice daily, versus oral amoxycillin–clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults
✍ Scribed by Patrick Petitpretz; Christian Chidiac; Francisco Soriano; Javier Garau; Katharine Stevenson; Elisabeth Rouffiac
- Book ID
- 119563466
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 150 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0924-8579
No coin nor oath required. For personal study only.